Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

113.52

Today's Change

+1.42 (1.26%)

Day's Change

112.06 - 113.93

Trading Volume

137,080

Overview

Market Cap

11 Billion

Shares Outstanding

104 Million

Avg Volume

334,732

Avg Price (50 Days)

102.84

Avg Price (200 Days)

89.45

PE Ratio

172.00

EPS

0.66

Earnings Announcement

15-Feb-2024

Previous Close

112.10

Open

112.10

Day's Range

112.06 - 113.93

Year Range

58.6 - 113.93

Trading Volume

137,080

Price Change Highlight

1 Day Change

1.27%

5 Day Change

5.13%

1 Month Change

11.46%

3 Month Change

8.32%

6 Month Change

39.00%

Ytd Change

17.88%

1 Year Change

88.41%

3 Year Change

143.29%

5 Year Change

477.71%

10 Year Change

14001.86%

Max Change

9771.30%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment